miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 501–600 of 767
Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation
Ghosh, S., Mahalanobish, S., & Sil, P. C. (2021) · The Nucleus · doi:10.1007/s13237-021-00376-x · Cited by 13
“miR-375 knock out mice exhibits diminished β-cell mass as miR-375 inhibits the activity of Cadm1 which represses G1/S transition and cellular growth [98].”
BackgroundMolecular Mechanisms of Nutrient-Mediated Regulation of MicroRNAs in Pancreatic β-cells
Sałówka, A., & Martínez-Sánchez, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.704824 · Cited by 15
Metabolic Dysfunction Biomarkers as Predictors of Early Diabetes
Luís, C., Baylina, P., Soares, R. A., & Fernandes, R. (2021) · Biomolecules · doi:10.3390/biom11111589 · Cited by 16
Bhattacharya, M., Ghosh, S., Malick, R. C., Patra, B. C., & Das, B. K. (2018) · Gene · doi:10.1016/j.gene.2018.09.008 · Cited by 14
MiR-221/222 Inhibit Insulin Production of Pancreatic β-Cells in Mice
Fan, L., Shan, A., Su, Y., Cheng, Y., Ji, H., Yang, Q., Lei, Y., Liu, B., Wang, W., Ning, G., et al. (2019) · Endocrinology · doi:10.1210/endocr/bqz027 · Cited by 13
Type of training has a significant influence on the GH/IGF-1 axis but not on regulating miRNAs
Khalid, K., Szewczyk, A., Kiszałkiewicz, J., Migdalska‐Sęk, M., Domańska-Senderowska, D., Brzeziański, M., Lulińska–Kuklik, E., Jegier, A., & Brzeziańska‐Lasota, E. (2020) · Biology of Sport · doi:10.5114/biolsport.2020.94248 · Cited by 14
MiR‐205 is up‐regulated in islets of diabetes‐susceptible mice and targets the diabetes gene Tcf7l2
Ouni, M., Gottmann, P., Westholm, E., Schwerbel, K., Jähnert, M., Stadion, M., Rittig, K., Vogel, H., & Schürmann, A. (2021) · Acta Physiologica · doi:10.1111/apha.13693 · Cited by 13
Takasawa, S., Shobatake, R., Takeda, Y., Uchiyama, T., Yamauchi, A., Makino, M., Sakuramoto‐Tsuchida, S., Asai, K., Ota, H., & Itaya‐Hironaka, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115868 · Cited by 13
“To date, a number of studies concerning the role of miR-375 have been reported to be influenced in normal pancreatic genesis [28], the proinflammatory macrophage response [29], pituitary prolactin synthesis [30], neuroendocrine differentiation and tumorigenesis in lung carcinoid cells [31], inhibition in proliferation…”
BackgroundWan, S., Xie, J., Liang, Y., & Yu, X. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01708-3 · Cited by 13
Sangali, P., Abdullahi, S., Nosrati, M., Khosravi-Asrami, O. F., Mahrooz, A., & Bagheri, A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01391-w · Cited by 12
“The deletion of miR-375 in ob/ ob mice has been linked to a decrease in beta-cell mass and the development of severe insulin-deficient diabetes [ 24]. miR-541, on the other hand, has been shown to play a role in mouse pancreas development and has also been linked to This study aimed to assess the…”
Circulating microRNAs in Diabetes Progression: Discovery, Validation, and Research Translation
Farr, R. J., Joglekar, M. V., & Hardikar, A. A. (2015) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0955-9_10 · Cited by 12
MicroRNAs and Diabetes Mellitus Type 1
Rezaei, N., Bahreini, F., & Rayzan, E. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210215111201 · Cited by 16
Heianza, Y., Krohn, K., Meir, A. Y., Wang, X., Ziesche, S., Ceglarek, U., Blüher, M., Keller, M., Kovacs, P. L., Shai, I., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2517 · Cited by 12
Ouyang, D., Miao, R., Wang, J., Liu, X., Xie, S., Ai, N., Dang, Q., & Liang, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.911769 · Cited by 12
“It is exciting that mir-375 can regulate the secretion of insulin (Poy et al., 2009).”
BackgroundAldous, N., Elsayed, A. K., Alajez, N. M., & Abdelalim, E. M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10515-3 · Cited by 12
“Previous studies reported that several miRNAs play crucial roles in regulating the development and function of pancreatic β-cells [12, 13, 18] and glucose homeostasis [19].”
BackgroundKnowledge mapping of exosomes in metabolic diseases: a bibliometric analysis (2007-2022)
Xu, F., Xia, C., Dou, L., & Huang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176430 · Cited by 12
Zacharjasz, J., Sztachera, M., Smuszkiewicz, M., & Piwecka, M. (2024) · FEBS Letters · doi:10.1002/1873-3468.14948 · Cited by 12
“Similarly, it has been recognized as enriched in pancreatic a and b cells, where it was implicated in insulin secretion [90], islet cell turn-over, and adaptive b cell expansion in response to increasing insulin demand in insulin resistance [91].”
Pokharel, D. R., Maskey, A., Kafle, R., Batajoo, A., Dahal, P., Raut, R., Adhikari, S., Manandhar, B., & Manandhar, K. D. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.07.001 · Cited by 14
“The miR-375, expressed abundantly in the pancreas, regulates α and β cell mass and insulin [32 – 34].”
BackgroundGender-dependent miR-375 promoter methylation and the risk of type 2 diabetes
Cheng, J. R., Wang, L., Xu, L., Wang, H., Liu, P., Bu, S., Ye, M., Zhang, L., Wang, Q., & Duan, S. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1069 · Cited by 13
Luzi, E., & Brandi, M. L. (2011) · Endocrine Practice · doi:10.4158/ep11062.ra · Cited by 12
microRNAs in Pancreatic β-Cell Physiology
Özcan, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22380-3_6 · Cited by 16
An optical method to evaluate both mass and functional competence of pancreatic α- and β-cells
Wang, Y., Han, C., Zhu, W., Wu, Z., Liu, Y., & Chen, L. (2016) · Journal of Cell Science · doi:10.1242/jcs.184523 · Cited by 12
“In contrast to this dogma, specific microRNAs and cytokines that maintain only α-cell mass but not β-cell mass are found to be upregulated in obesity and type 2 diabetes (Ellingsgaard et al., 2008; Guardado-Mendoza et al., 2013; Poy et al., 2009).”
BackgroundShaping and preserving β‐cell identity with microRNAs
Dumortier, O., Fabris, G., & OBBERGHEN, E. V. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12722 · Cited by 13
Martens, G. A., Stangé, G. M., Piemonti, L., Anckaert, J., Ling, Z., PIPELEERS, D. G., Gorus, F., Mestdagh, P., Smet, D. D., Vandesompele, J., et al. (2021) · Cells · doi:10.3390/cells10071693 · Cited by 12
Organogenesis and functional genomics of the endocrine pancreas
Bramswig, N. C., & Kaestner, K. H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0915-z · Cited by 14
Assmann, T. S., Cuevas‐Sierra, A., Salas‐Pérez, F., Riezu‐Boj, J. I., Milagro, F. I., & Martínez, J. A. (2020) · Chronobiology International · doi:10.1080/07420528.2020.1782419 · Cited by 12
Li, H., Tao, W., Xu, X., Chen, G., Wen-ping, M., & Jia, S. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105706 · Cited by 11
Locke, J. M., & Harries, L. W. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120049 · Cited by 11
High glucose reduces hepatic glycogenesis by suppression of microRNA-152
Zhao, X., Lu, Y., WANG, F., DOU, L., WANG, L., Guo, J., & Li, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2426 · Cited by 11
Thiel, G., & Rößler, O. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010815 · Cited by 10
“In β-cells, a miRNA designated miR-375 has been identified as essential for maintaining β-cells mass [44].”
BackgroundStuart, S. H., Cash-Ahmed, A. C., Kilikevicius, L., & Robinson, G. E. (2024) · Journal of Experimental Biology · doi:10.1242/jeb.246785 · Cited by 10
Carmona‐Maurici, J., Ricart-Jané, D., Viñas, A., López-Tejero, M. D., Eskubi-Turró, I., Miñarro, A., Baena‐Fustegueras, J. A., Peinado‐Onsurbe, J., & Pardina, E. (2024) · Obesity Facts · doi:10.1159/000541175 · Cited by 13
β-cell preservation and regeneration for diabetes treatment: where are we now?
Karadimos, M., Kapoor, A., Khattabi, I. E., & Sharma, A. (2012) · Diabetes Management · doi:10.2217/dmt.12.21 · Cited by 10
Dai, B., Yang, T., Shi, X., Ma, N., Kang, Y., Zhang, J., & Zhang, Y. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.028 · Cited by 11
Mapping the Pax6 3’ untranslated region microRNA regulatory landscape
Ryan, B. C., Lowe, K., Hanson, L., Gil, T., Braun, L., Howard, P. L., & Chow, R. L. (2018) · BMC Genomics · doi:10.1186/s12864-018-5212-x · Cited by 11
“with a corresponding increase in the number of glucagon positive cells [109].”
Soltani, A., Soleimani, M., Ghiass, M. A., Enderami, S. E., Rabbani, S., Jafarian, A., & Allameh, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119338 · Cited by 10
Chen, X., Sokirniy, I., Wang, X., Jiang, M. H., Mseis-Jackson, N., Williams, C., Mayes, K., Jiang, N., Puls, B., Du, Q., et al. (2023) · Cells · doi:10.3390/cells12172202 · Cited by 11
Nucleic acid biomarkers of β cell stress and death in type 1 diabetes
Syed, F., & Evans‐Molina, C. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000261 · Cited by 11
The Predominant microRNAs in β-cell Clusters for Insulin Regulation and Diabetic Control
Soltani, A., Jafarian, A., & Allameh, A. (2019) · Current Drug Targets · doi:10.2174/1389450121666191230145848 · Cited by 12
Wang, X., Gou, D., & Xu, S.-Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008430 · Cited by 11
“. Obese mice exhibit increased miR-375 expression, and genetic deletion of miR-375 resulted in a severe diabetes”
BackgroundMicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker
Pierantoni, M., Dell’Aira, M., Grassilli, S., Brugnoli, F., & Bertagnolo, V. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i10.110097 · Cited by 10
Wang, Z., Gai, Y., Zhou, J., Liu, J., & Cui, S. (2019) · Stress · doi:10.1080/10253890.2018.1561845 · Cited by 9
“Previous reports confirmed that miR375 localizes in mouse and rat adrenal medullary cells (Gai et al., 2017; Poy et al., 2009), and miR-375 has been demonstrated to be required for CATs synthesis in rats exposed to stress (Gai et al., 2017).”
BackgroundConsequences of the exposome to gestational diabetes mellitus
Rudge, M. V. C., Alves, F. C. B., Hallur, R. L. S., de Oliveira, R. G., Vega, S., Reyes, D. R. A., Floriano, J. F., Prudêncio, C. B., Garcia, G. A., Reis, F. V. D. S., et al. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130282 · Cited by 11
Diabetes and associated cardiovascular complications: The role of microRNAs
Mačvanin, M., & Isenović, E. R. (2023) · Cardiology Plus · doi:10.1097/cp9.0000000000000062 · Cited by 11
“MiR-375 targets the gene encoding myotrophin (MTPN), a protein that promotes the fusion of insulin vesicles with β -cell membranes via its role in actin filament depolymerization and, consequently, cytoskeleton remodeling [29] and exocytosis [29,38] .”
BackgroundRole of identified noncoding RNA in erectile dysfunction
Chen, S., Sun, X., Wu, S., Jiang, J., Zhu, C., Xu, K., & Xu, K. (2020) · Andrologia · doi:10.1111/and.13596 · Cited by 10
“By inhibiting insulin secretion and pancreatic α- and β-cell mass, miRNA-375 is overexpressed in islet cells (β-cells and non-β-cells), which can influence glucose homoeostasis (Joglekar, Joglekar, & Hardikar, 2009; Poy et al., 2009).”
BackgroundmiR-375 acts as a novel factor modulating pituitary prolactin synthesis through Rasd1 and Esr1
Zhang, J., Gao, J., Zhang, D., Liu, H., Gou, K., & Cui, S. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0001 · Cited by 9
Progress in micro RNA focused research in endocrinology
Voglova, K., Bezakova, J., & Herichová, I. (2016) · Endocrine Regulations · doi:10.1515/enr-2016-0012 · Cited by 9
Mao, Y., Schoenborn, J., Wang, Z., Chen, X., Matson, K., Mohan, R., Zhang, S., Tang, X., Arunagiri, A., Arvan, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16174-7 · Cited by 9
Matarid, T. R., Rayan, M., Hussein, O., Abunada, H. H., Maayah, Z. H., & Korashy, H. M. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.11801 · Cited by 8
“Data from an experimental study using miR-375 KO and miR-375/obese KO mice revealed hyperglycemia due to an increase in pancreatic α -cell mass, impaired glucose tolerance, and reduced insulin secretion—hallmarks of insulin resistance in the miR-375 KO group [114].”
Khoshnazar, S. M., Salarizadeh, N., Mohammad-Sadeghipour, M., Shahpar, A., Izadi, M., Behzadnia, M. J., Khoozani, M. F., Alimohammadi, M., Farahani, N., & Hushmandi, K. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00677-9 · Cited by 9
Darlington, K., Shumway, A. J., Sona, C., Khaled, Z., Steinbach, E. C., Kikuchi, Y., Fan, S., Gartner, V., Clough, K., Nishiyama, N. C., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101618 · Cited by 9
Self-citationA comprehensive overview on Micro RNA signature in type 2 diabetes Mellitus and its complications
Mishra, S., Bahinipati, J., Sarangi, R., Mohapatra, S. R., Das, S., & Mishra, A. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01069-1 · Cited by 8
Hochberg, J. T., Sohal, A., Handa, P., Maliken, B. D., Kim, T.-K., Wang, K., Gochanour, E. M., Li, Y., Rose, J. B., Nelson, J. E., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100729 · Cited by 10
Sharma, K., Saini, N., & Hasija, Y. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.11.004 · Cited by 8
Pan, G., Liu, Q., Xin, H., & Liu, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.058 · Cited by 8
miR‐720 Regulates Insulin Secretion by Targeting Rab35
Lu, C., Wang, D., Feng, Y., Feng, L., & Li, Z. (2021) · BioMed Research International · doi:10.1155/2021/6662612 · Cited by 9
Present Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus
Chhabra, P., Clark, D. L., Daniel, J., & Kenneth, L. B. (2011) · InTech eBooks · doi:10.5772/22343 · Cited by 10
Yan, X., Wang, Z., Westberg-Rasmussen, S., Tarbier, M., Rathjen, T., Tattikota, S. G., Peck, B. C. E., Kanke, M., Oxvig, C., Frystyk, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01365 · Cited by 8
Self-citationRole of microRNA in pancreatic beta cell function
Brozzi, F. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.012 · Cited by 13
Luo, G., Wang, S., Ai, Y., Li, J., & Ren, Z. (2022) · Biology · doi:10.3390/biology11070944 · Cited by 8
Hinault, C., Dumortier, O., & OBBERGHEN, E. V. (2013) · médecine/sciences · doi:10.1051/medsci/2013298019 · Cited by 8
Control of hepatic gluconeogenesis by Argonaute2
Yan, X., Wang, Z., Bishop, C. A., Weitkunat, K., Feng, X. M., Tarbier, M., Luo, J., Friedländer, M. R., Burkhardt, R., Klaus, S., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.10.003 · Cited by 11
Self-citationXie, H., Zhang, Y., Tan, X., Zheng, Y., Ni, H., Dong, L., Zheng, J., Diao, J., Yin, Y., Zhang, J., et al. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0078 · Cited by 7
“Some researchers have reported that miR-375 was a key regulator for maintaining glucose homeostasis, and it was essential during the expansion procedure of b cells (Poy et al. , 2009).”
Shoeibi, S., Gou, W., Yeung, T., Helke, K. L., Green, E., Strange, C., & Wang, H. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.028 · Cited by 7
Dual regulation of miR-375 and CREM genes in pancreatic beta cells
Keller, D. M., & Perez, I. G. (2022) · Islets · doi:10.1080/19382014.2022.2060688 · Cited by 8
Francis, N., Moore, M. L., Asan, S. G., Rutter, G. A., & Burns, C. J. (2015) · Gene Expression Patterns · doi:10.1016/j.gep.2015.08.001 · Cited by 8
Predicting the function of islets after transplantation
Darden, C. M., Farrow, A. E., Rajan, S. K., Lakhani, M., Lawrence, M. C., & Naziruddin, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00044-7 · Cited by 10
Let7b-5p inhibits insulin secretion and decreases pancreatic β-cell mass in mice
Ji, H., Fan, L., Shan, A., Wang, W., Ning, G., Cao, Y., & Jiang, X. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111506 · Cited by 7
Sebastiani, G., Mancarella, F., Ventriglia, G., Valentini, M., Grieco, G., Nigi, L., & Dotta, F. (2015) · RNA & DISEASE · doi:10.14800/rd.593 · Cited by 8
miRNAs in the Pathophysiology of Diabetes and Their Value as Biomarkers
Brennan, E. P., McClelland, A., Hagiwara, S., Godson, C., & Kantharidis, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00031-0 · Cited by 10
Jeffery, N. M., & Harries, L. W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111559 · Cited by 8
Sazdova, I., Gagov, H., Hadzi‐Petrushev, N., Konaktchieva, M. N., Konakchieva, R., & Mladenov, M. I. (2026) · Applied Sciences · doi:10.3390/app16063027 · Cited by 6
Wáng, Y., Liu, J., Zhu, S., Hu, S.-L., Chen, X., Mandon, E. C., Tran, N. T., Zhang, S., Qi, Y., Ma, H., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.038 · Cited by 6
Expression signatures and roles of Micro RNA s in human oesophageal adenocarcinomas
Kong, X., Gong, S., Su, L., Li, C., & Kong, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13300 · Cited by 7
“Another study indicated that the pancreatic alpha-cell mass of miR-375-deficient mice was decreased, and these mice were hyperglycaemic, indicating that proliferation was impaired [36].”
BackgroundYin, L., Zhang, T., Wei, Y., Cai, W., Feng, G. L., Chang, X., & Sun, K. (2017) · PubMed · Cited by 6
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells
Lin, X., Cheng, L., Wan, Y., Yan, Y., Zhang, Z., Li, X., Wu, J., Wang, X., & Xu, M. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230206121715 · Cited by 6
“…target genes in the study of biological function of islet β cells are mainly divided into three categories [30]: Genes related to pancreatic development (such as Sox17, Sox9., etc. ) [51], cell proliferation (such as Cav1, Id3., etc. ) [52] and insulin secretion (including MTPN [28] and PDK1 [36]).”
Restored UBE2C expression in islets promotes β-cell regeneration in mice by ubiquitinating PER1
Jiang, H., Zheng, S., Qian, Y., Zhou, Y., Dai, H., Liang, Y., He, Y., Gao, R., Lv, H., Zhang, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04868-8 · Cited by 6
Kitamura, R. A., Hummel, D., Ustione, A., Piston, D. W., & Urano, F. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411234121 · Cited by 6
Ishimura, M., Sakurai‐Yageta, M., Maruyama, T., Ando, T., Fukayama, M., Goto, A., & Murakami, Y. (2012) · Journal of Cancer Therapy · doi:10.4236/jct.2012.324050 · Cited by 6
Lessons from basic pancreatic beta cell research in type-2 diabetes and vascular complications
Eliasson, L., Esguerra, J. L. S., & Wendt, A. (2017) · Diabetology International · doi:10.1007/s13340-017-0304-4 · Cited by 7
MicroRNAs: An adaptive mechanism in the pancreatic β-cell…and beyond?
Poy, M. N. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.07.003 · Cited by 6
Self-citationSuhiman, M. S., Mohamad, M. A., Asnawi, A. W. A., Hayati, A. R., Azma, M. M., Syahrina, A. R. N., Nazefah, A. H., Jameela, S., & Fariha, M. M. N. (2016) · PubMed · Cited by 6
Unique circulating microRNA associations with dysglycemia in people living with HIV and alcohol use
Bourgeois, B. L., Lin, H., Yeh, A. Y., Levitt, D. E., Primeaux, S. D., Ferguson, T. F., Molina, P. E., & Simon, L. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00085.2021 · Cited by 6
Network-based insights into miRNA regulation of β-cell insulin secretion in type 2 diabetes
Cowan, E., Karagiannopoulos, A., Pollastri, A., Asai, A., Nagao, M., Maziarz, M., Esguerra, J. L. S., & Eliasson, L. (2025) · iScience · doi:10.1016/j.isci.2025.114200 · Cited by 5
The Role of MicroRNAs in the Induction of Pancreatic Differentiation
Sabouri, E., Rajabzadeh, A., Enderami, S. E., Saburi, E., Soleimanifar, F., Barati, G., Rahmati, M., Khamisipour, G., & Enderami, S. E. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200621173607 · Cited by 5
Chen, H., Zhang, M., Zhang, J., Chen, Y., Zuo, Y., Xie, Z., Zhou, G., Chen, S., & Chen, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.899831 · Cited by 6
MicroRNAs in chronic pediatric diseases (Review)
Zhang, M., & Han, Y. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12388 · Cited by 6
MicroRNAs in diabetes mellitus
Ali, P. S. S., Ahmad, M. P., & Parveen, K. M. H. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01591-y · Cited by 5
Re‐dicing the pancreatic β‐cell: do microRNAs define cellular identity?
Tattikota, S. G., & Poy, M. N. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.31 · Cited by 5
“Previous observations with the miR-375 knockout mouse illustrate an effect on pancreatic b-cell mass that becomes more pronounced when crossed with the leptin-deficient obob mouse, a model of severe hyperglycaemia and insulin resistance (Poy et al, 2009).”
BackgroundSelf-citationStubbusch, J., Narasimhan, P., Hennchen, M., Huber, K., Unsicker, K., Ernsberger, U., & Rohrer, H. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.01.026 · Cited by 5
Circulating salivary and serum miRNA-182, 320a, 375 and 503 expression levels in type 2 diabetes
Monfared, Y. K., Honardoost, M., Cea, M., Gholami, S., Mirzaii‐Dizgah, I., Hashemipour, S., Sarookhani, M. R., & Farzam, S. A. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01082-4 · Cited by 5
Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
Wang, H. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673264615231124072130 · Cited by 5
miRNA Biology in Pathological Processes
Zhang, X., Dong, H., & Tian, Y. (2015) · Springer briefs in molecular science · doi:10.1007/978-3-662-47293-4_2 · Cited by 6
Connexins and microRNAs: Interlinked players in regulating islet function?
Umrani, M. R., Joglekar, M. V., Glover, E. S., Wong, W. K. M., & Hardikar, A. A. (2017) · Islets · doi:10.1080/19382014.2017.1331192 · Cited by 5
Let-7e-5p Regulates GLP-1 Content and Basal Release From Enteroendocrine L Cells From DIO Male Mice
Handgraaf, S., Dusaulcy, R., Visentin, F., Philippé, J., & Gosmain, Y. (2019) · Endocrinology · doi:10.1210/endocr/bqz037 · Cited by 5
Potential of miRNAs in cervical cancer chemoresistance
Karimi, F., & Mollaei, H. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101109 · Cited by 5
Ernsberger, U. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2049-8 · Cited by 5
Lyu, X., Wang, J., Xia, G., Wu, G., Jiao, Y., Faleti, O. D., Liu, P., Liu, T., Long, Y., Chong, T., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008532 · Cited by 5
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes
Grieco, G. E., Dotta, F., & Sebastiani, G. (2025) · Personalized Medicine · doi:10.1080/17410541.2025.2563498 · Cited by 4
Vukelić, I., Sefedini, A., Detel, D., Buljević, S., Šuša, B., Tesovnik, T., Giorgino, F., Battelino, T., Rahelić, D., & Majanović, S. K. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02114-2 · Cited by 4
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.